Correlation Between Acumen Pharmaceuticals and Entero Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Entero Therapeutics,, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Entero Therapeutics,.

Diversification Opportunities for Acumen Pharmaceuticals and Entero Therapeutics,

0.61
  Correlation Coefficient

Poor diversification

The 3 months correlation between Acumen and Entero is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Entero Therapeutics, go up and down completely randomly.

Pair Corralation between Acumen Pharmaceuticals and Entero Therapeutics,

Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to generate 0.82 times more return on investment than Entero Therapeutics,. However, Acumen Pharmaceuticals is 1.22 times less risky than Entero Therapeutics,. It trades about -0.12 of its potential returns per unit of risk. Entero Therapeutics, is currently generating about -0.22 per unit of risk. If you would invest  280.00  in Acumen Pharmaceuticals on August 23, 2024 and sell it today you would lose (49.00) from holding Acumen Pharmaceuticals or give up 17.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Acumen Pharmaceuticals  vs.  Entero Therapeutics,

 Performance 
       Timeline  
Acumen Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Acumen Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Entero Therapeutics, 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Entero Therapeutics, are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Entero Therapeutics, displayed solid returns over the last few months and may actually be approaching a breakup point.

Acumen Pharmaceuticals and Entero Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Acumen Pharmaceuticals and Entero Therapeutics,

The main advantage of trading using opposite Acumen Pharmaceuticals and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.
The idea behind Acumen Pharmaceuticals and Entero Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators